IPMC Inc. Information

IPMC, established on March, 16, 2016, by the co-founder and CEO Mr. Youngwoo Jang, and co-founder Dr. Robert Hariri, founder and CEO of Celgene Cellular Therapeutics, and Co-founder of Human Longevity. IPMC is the world’s first precision medical service and community complex platform focused on cell therapy. IPMC contributes to scientific development and discovery for effective treatment methods for human diseases. IPMC is also taking a pioneering role in the standardization of future medicine, not only focusing on becoming a base for a service-centric Precision Medicine business focused on genome and bio convergence technology, but also serve as a global innovative technology & knowledge hub. An initiative to bring together industry, academic, and government leaders through the organization of the world’s largest personalized medicine and preventative medicine conference. IPMC builds partnerships with global companies, and operates a corporation based on a team of researchers in the fields of medicine, biotechnology and ICT, all for successful precision medical care. IPMC’s business has 6 major sectors: ■ Precision Medicine diagnostic platform offering genomic data generation and analysis and clinical application ■ Cohort research and genomic data accumulation for diversified genomic information by race, gender, and age ■ Stem cell banking (cord blood, placenta blood, and tissue), NIPT(Non-Invasive Prenatal Test) and newborn genome analysis service ■ Personalized cell therapy based on genomic analysis ■ Personalized medical examination ■ Wellness programs for the elderly including personalized bio-nutrition product and services to prevent and treat sarcopenia